Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
BJU Int. 2010 Oct;106(7):1042-4. doi: 10.1111/j.1464-410X.2010.09230.x. Epub 2010 Mar 4.
To report the risk factors and natural history of urinary fistula (UF) after partial nephrectomy (PN), as their incidence has been reported to be 3-6% in large series of PN but there are few reports of the risk factors associated with the development of UF after PN, and the natural history of UF in a large group of patients.
This was a retrospective review of 1118 PN at one tertiary-care institution. Most patients had a drain placed in the perinephric space after surgery. Fifty-two patients were identified as having a UF if they had persistent flank drainage for >14 days after surgery, or presented with evidence of a UF after the drain had been removed. Risk factors for development and the course of the UF are reported.
Fifty-two patients developed a UF after PN (4.4%, 95% confidence interval, CI, 3.5-6.1%) The rate of a persistent urine leak (defined as drain fluid consistent with urine for >2 weeks after surgery) was 4.0 (95% CI 2.9-5.3)%. The overall rate of delayed UF presentation was only 0.4 (0.09-0.9)%. Patients who developed a UF had larger tumours (3.5 vs 2.6 cm, P= 0.03), a higher estimated blood loss (400 vs 300 mL, P < 0.001), and longer ischaemia time (50 vs 39 min, P < 0.001) than patients who did not develop a UF. Differences in tumour histology, laterality, multifocality, type of surgery (laparoscopic vs open), and intraoperative collecting system entry were not statistically different in patients who did or did not develop a UF. Patients with tumours of >2.5 cm were twice as likely to develop a UF than patients with tumours of <2.5 cm (P= 0.02). Most patients were managed conservatively with a percutaneous drain until the UF resolved, if they were asymptomatic. Overall, in 36 patients (69%) the fistula resolved with no intervention, while 16 (31%) required intervention. Stenting was the commonest intervention (15%). No patient required re-operative open surgery.
The rate of development of UF after PN is low. Tumour size, blood loss and ischaemia time were all associated with the development of a UF. In most patients with a urine leak immediately after surgery the UF will resolve with no intervention, and can be managed conservatively with patience, in the absence of clinical symptoms.
报告部分肾切除术(PN)后尿瘘(UF)的风险因素和自然病程,因为在大量 PN 系列中报告其发生率为 3-6%,但很少有报告与 PN 后 UF 发展相关的风险因素,以及 UF 在大量患者中的自然病程。
这是对一家三级医疗机构的 1118 例 PN 的回顾性分析。大多数患者在手术后在肾周间隙放置引流管。如果患者术后持续引流>14 天,或在引流管拔除后出现 UF 证据,则将 52 例患者确定为 UF。报告了 UF 发展的风险因素和 UF 的病程。
52 例患者在 PN 后发生 UF(4.4%,95%置信区间,CI,3.5-6.1%)。持续性尿漏(定义为手术后引流液与尿液一致>2 周)的发生率为 4.0%(95%CI 2.9-5.3%)。UF 延迟表现的总体发生率仅为 0.4%(0.09-0.9%)。发生 UF 的患者肿瘤更大(3.5 厘米 vs 2.6 厘米,P=0.03),估计失血量更多(400 毫升 vs 300 毫升,P<0.001),缺血时间更长(50 分钟 vs 39 分钟,P<0.001)比未发生 UF 的患者。发生 UF 和未发生 UF 的患者的肿瘤组织学、侧别、多发性、手术类型(腹腔镜与开放)和术中集合系统进入均无统计学差异。肿瘤>2.5 厘米的患者发生 UF 的可能性是肿瘤<2.5 厘米的患者的两倍(P=0.02)。大多数无症状患者通过经皮引流保守治疗直至 UF 消退。总体而言,36 例(69%)患者 UF 自行消退,无需干预,16 例(31%)患者需要干预。支架置入是最常见的干预措施(15%)。无患者需要再次开放手术。
PN 后 UF 的发展率较低。肿瘤大小、失血量和缺血时间均与 UF 的发生有关。大多数患者在手术后立即出现尿漏时,UF 会自行消退,如果没有临床症状,可以通过耐心的保守治疗进行管理。